Company profile: Nerviano Medical Sciences
1.1 - Company Overview
Company description
- Provider of oncology research and development services, including drug discovery, preclinical research, clinical development, and manufacturing, serving local and international markets. Offers Entrectinib, a kinase inhibitor for ROS1 fusionβpositive lung cancer and NTRK gene fusion solid tumors, designed to cross the bloodβbrain barrier and address CNS metastases.
Products and services
- Clinical Development: Conducts human clinical trials for oncology drugs, comprehensively testing safety and efficacy in patients to demonstrate clinical performance
- Clinical-stage
- Entrectinib: Kinase inhibitor for ROS1 fusionβpositive lung cancer and solid tumors with NTRK gene fusions, engineered to cross the bloodβbrain barrier and treat CNS metastases
- CNSβpenetrant
- Oncology Drug Discovery: Develops new anticancer drug candidates through dedicated oncology R&D, enabling local and international markets to obtain active ingredients and medicines
- Researchβgrade
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Nerviano Medical Sciences
IsoRay
HQ: United States
Website
- Description: Provider of state-of-the-art, personalized brachytherapy products that offer more cost-effective cancer treatment, utilizing a unique isotope for the treatment of both common and difficult-to-treat cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full IsoRay company profile β
Sanarus
HQ: United States
Website
- Description: Provider of minimally invasive devices for the diagnosis and treatment of breast tumors, including the Visica treatment system for cryoablation of breast fibroadenomas; the Cassi II rotational core biopsy system, an automated hand held breast biopsy device to secure contiguous biopsy samples; and the ImarC tissue marker system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Sanarus company profile β
Novelos Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical research, development, and commercialization focused on oxidized glutathione.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Novelos Therapeutics company profile β
Naviscan
HQ: United States
Website
- Description: Provider of organ-specific molecular imaging, designing, manufacturing, and distributing high-resolution PET scanners that provide unprecedented visualization of small body parts and can image virtually any body part that fits into the gantry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Naviscan company profile β
Scorpion Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage precision oncology therapeutics, developing small-molecule inhibitors targeting the H1047X-mutant PI3KΞ± in solid tumors (STX-H1047-PI3KΞ±) and exon 20 insertion mutations in EGFR driving non-small cell lung cancer (STX-EGFR-EXON20).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Scorpion Therapeutics company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Nerviano Medical Sciences
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nerviano Medical Sciences
2.2 - Growth funds investing in similar companies to Nerviano Medical Sciences
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Nerviano Medical Sciences
4.2 - Public trading comparable groups for Nerviano Medical Sciences
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β